Cargando…

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer

PURPOSE: Lenvatinib has shown efficacy in treating radioiodine-refractory differentiated thyroid cancer (RR-DTC) in the multinational phase III SELECT study; however, it has not been tested in Chinese patients with RR-DTC. PATIENTS AND METHODS: Chinese patients with confirmed RR-DTC (n = 151) were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiangqian, Xu, Zhengang, Ji, Qinghai, Ge, Minghua, Shi, Feng, Qin, Jianwu, Wang, Feng, Chen, Guang, Zhang, Yuan, Huang, Rui, Tan, Jian, Huang, Tao, Li, Sijin, Lv, Zhongwei, Lin, Yansong, Guo, Zhuming, Kubota, Tomoki, Suzuki, Takuya, Ikezawa, Hiroki, Gao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401493/
https://www.ncbi.nlm.nih.gov/pubmed/34326132
http://dx.doi.org/10.1158/1078-0432.CCR-21-0761